Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × Sevoflurane × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Pituitary Neoplasms 1 Pain, Postoperative 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Melanoma 1 Liver Functions Tests 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Tumor Adult 1

Interventions

Nivolumab 22 pembrolizumab 16 Ipilimumab 13 Temozolomide 11 toripalimab 9 Biopsy 8 Dacarbazine 7 Blood Specimen Collection 7 Cyclophosphamide 6 trametinib 5 fludarabine 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 durvalumab 4 binimetinib 4 aldesleukin 4 Interleukin-2 4 Injections 4 Gene Expression Profiling 4 Chemotherapy, Adjuvant 4 palbociclib 3 encorafenib 3 apatinib 3 Sorafenib 3 Introns 3 Cisplatin 3 Carboplatin 3 Canvaxin 3 Bevacizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01588847 2014-12-11

Anesthesia and Cancer Recurrence im Malignant Melanoma

University Hospital Muenster

Phase NA Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡